Zoloft and Osteoradionecrosis - a phase IV clinical study of FDA data

Summary:

Osteoradionecrosis is reported as a side effect among people who take Zoloft (sertraline hydrochloride), especially for people who are female, 60+ old, also take Zometa, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Osteoradionecrosis when taking Zoloft. It is created by eHealthMe based on reports of 128,159 people who have side effects when taking Zoloft from the FDA, and is updated regularly.

What is Zoloft?

Zoloft has active ingredients of sertraline hydrochloride. It is often used in depression. eHealthMe is studying from 138,798 Zoloft users. Check the latest studies of Zoloft.

What is Osteoradionecrosis?

Osteoradionecrosis (irradiation of bones causes damage to osteocytes and impairs the blood supply) is found to be associated with 329 drugs and 166 conditions by eHealthMe. Check the latest studies of Osteoradionecrosis.

On Jul, 08, 2026

128,159 people reported to have side effects when taking Zoloft.
Among them, 45 people (0.04%) have Osteoradionecrosis.

Among these 45 people:

What is the gender of people who have Osteoradionecrosis when taking Zoloft? *

female: 62.79 %
male: 37.21 %

What is the age of people who have Osteoradionecrosis when taking Zoloft? *

What are other drugs people take besides Zoloft? *

What are other side effects people have besides Osteoradionecrosis? *

Spinal Osteoarthritis (joint cartilage loss in spine): 42 people, 93.33%
Chest Pain: 41 people, 91.11%
Pain: 41 people, 91.11%
Anaemia (lack of blood): 40 people, 88.89%
Bone Disorder: 34 people, 75.56%
Tooth Abscess (pus formation in tooth): 32 people, 71.11%
Dental Caries: 32 people, 71.11%
Osteonecrosis Of Jaw (death of bone of jaw): 31 people, 68.89%
Tumor: 31 people, 68.89%
Emotional Distress: 31 people, 68.89%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 20 people, 44.44%
Trismus (reduced opening of the jaws): 17 people, 37.78%
Pain In Jaw: 13 people, 28.89%
Neoplasm Malignant (cancer tumour): 13 people, 28.89%
Pain: 12 people, 26.67%
Metastases To Bone (cancer spreads to bone): 4 people, 8.89%
Breast Cancer Metastatic: 4 people, 8.89%
Spinal Compression Fracture (fracture due to spinal compression on bone): 2 people, 4.44%
Osteoporosis (bones weak and more likely to break): 2 people, 4.44%
Trigeminal Neuralgia (a painful condition of the nerve responsible for most facial sensation): 1 person, 2.22%

* Approximation only. Some reports may have incomplete information.

Do you take Zoloft and have Osteoradionecrosis?

- Check whether Osteoradionecrosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zoloft:

Zoloft (138,798 reports)

Browse all side effects of Zoloft:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Osteoradionecrosis:

Osteoradionecrosis (329 drugs)

Browse all the conditions that are associated with Osteoradionecrosis:

Osteoradionecrosis (166 conditions)

Related publications that referenced our studies

Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .
Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F, "Severe hypokalemia probably associated with sertraline use", Annals of Pharmacotherapy, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on sertraline hydrochloride (the active ingredients of Zoloft) and Zoloft (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.